生物标志物 生物标志物
Thanakit Pongpitakmetha1,2,3,4, Thanapoom Taweephol5, Nattanich Pornteparak6
1Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
血质纤维酸蛋白 (GFAP) 与大脑小血管疾病 (CSVD) 的负担相关,特别是在非阿尔茨海默氏症患者中.
科学领域:
- 神经学 神经学
- 神经成像是一种神经成像.
- 生物标志物 生物标志物
背景情况:
- 大脑小血管疾病 (CSVD) 是血管认知障碍和痴呆症 (VCID) 的首要原因,也是阿尔茨海默病 (AD) 的潜在共同病理.
- 血质纤维酸蛋白 (GFAP) 可能表明星细胞症,这是一种涉及到CSVD和AD的过程.
- 了解CSVD生物标志物与血GFAP之间的关系对于诊断和管理认知衰退至关重要.
研究的目的:
- 在记忆诊所队列中评估CSVD的神经成像生物标志物和血GFAP水平之间的相关性.
- 调查这种相关性是否在患有阿尔茨海默病 (AD) 和没有阿尔茨海默病 (AD) 的患者之间有所不同.
- 探索AD生物标志物对CSVD和血GFAP之间的关系的影响.
主要方法:
- 从114名参与者收集了记忆诊所的临床信息和血生物标志物.
- 使用已确定的标准 (CSF Aβ 42/p-tau181比或Aβ PET) 将患者分为AD和非AD组.
- 使用基于MRI的STRIVE-2标准评估CSVD并计算综合总CSVD得分;使用非参数统计数据分析相关性.
主要成果:
- 在整体队列和非AD组中,总体CSVD得分和血GFAP之间发现了显著的正相关性.
- 这种相关性在调整血p-tau 217,一个关键的AD生物标志物后,在整个队列中大大加强.
- 特定的CSVD神经成像生物标志物与血GFAP呈现出正相关性,尽管并非在所有标志物中普遍存在.
结论:
- 在没有AD的个体中,CSVD负担和血GFAP之间的相关性比AD的个体更强.
- 对像p-tau 217这样的AD生物标志物的调整增强了CSVD得分和血GFAP之间观察到的相关性.
- 由于病理机制的重叠,单独的血GFAP可能在反映AD患者的CSVD负担方面存在局限性;建议进一步研究VCID的其他液体生物标志物.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


